0JDK Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Iovance Biotherapeutics Inc

Watchlist Manager

Watchlist

Price: 3.97 USD 1.79%

Market Cap: $53.3B

I	Iovance Biotherapeutics Inc LSE:0JDK	US
	Oxford Nanopore Technologies PLC LSE:ONT	UK
	Katoro Gold PLC LSE:KAT	UK
	GS Yuasa Corp TSE:6674	JP
	Chemistree Technology Inc OTC:CHMJD	CA
	Merdeka Copper Gold Tbk PT IDX:MDKA	ID
	Recruit Holdings Co Ltd TSE:6098	JP
	ACM Research Inc NASDAQ:ACMR	US
	Byron Energy Ltd ASX:BYE	AU
P	Pantai Indah Kapuk Dua Tbk PT IDX:PANI	ID
	Toughbuilt Industries Inc OTC:TBLT	US
	Frontier Group Holdings Inc NASDAQ:ULCC	US
	Surya Semesta Internusa Tbk PT IDX:SSIA	ID
	Loop Industries Inc NASDAQ:LOOP	CA

Profitability Summary

Iovance Biotherapeutics Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Healthy Gross Margin

37%

Negative 3Y Average Gross Margin

-256%

Negative Operating Margin

-127%

Negative 3Y Average Operating Margin

-25 626%

Negative Net Margin

-124%

Negative 3Y Average Net Margin

-24 935%

Negative Free Cash Flow Margin

-107%

Negative 3Y Average Free Cash Flow Margin

-21 417%

Negative ROE

-48%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-96%

ROIC is Increasing

-229% > -63%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.